4//SEC Filing
OncoMed Pharmaceuticals Inc 4
Accession 0001140361-15-009202
CIK 0001302573operating
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 7:49 PM ET
Size
4.7 KB
Accession
0001140361-15-009202
Insider Transaction Report
Form 4
Lasky Laurence
Director
Transactions
- Other
Common Stock
2015-02-24+1,450→ 2,899 total
Footnotes (1)
- [F1]The reporting person received the shares for no consideration as part of a pro-rata distribution of shares by funds controlled by Latterell Venture Partners.
Documents
Issuer
OncoMed Pharmaceuticals Inc
CIK 0001302573
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001302573
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 7:49 PM ET
- Size
- 4.7 KB